How less can be more when treating some kidney cancers

A new Mayo Clinic study suggests that removing the entire kidney from younger patients with small kidney tumors may lead to decreased overall survival compared with an operation that removes the tumor but leaves the kidney intact. The study will be published in the February issue of the Journal of Urology.

Radical nephrectomy is a surgical procedure to remove the entire kidney along with the adrenal gland that sits atop the kidney and adjacent lymph nodes. In a partial nephrectomy, only the tumor is removed, sparing the surrounding normal kidney tissue.

“For patients with small kidney tumors, removal of the entire kidney may be associated with long-term consequences that we did not previously recognize when compared to removal of just the tumor,” says the study’s lead author, R. Houston Thompson, M.D., a Mayo Clinic urologist currently serving a fellowship at Memorial Sloan-Kettering Cancer Center. “Recent evidence suggests that there is a graded impact on survival based on declining overall kidney function. So as kidney function declines, the risk of heart attacks and heart-related events goes up, and consequently the risk of death from these events goes up.”

In this retrospective study, the research team reviewed the cases of 648 Mayo Clinic patients who underwent either a partial or radical nephrectomy for a kidney tumor 4 centimeters or smaller. In the 327 patients younger than 65 years of age, radical nephrectomy was significantly associated with death from any cause when compared with partial nephrectomy. Ten-year overall survival rates were 82 percent for patients treated with a radical nephrectomy and 93 percent for patients treated with a partial nephrectomy.

“We know the survival from cancer with partial nephrectomy or radical nephrectomy for patients with these small masses is excellent,” says Michael Blute, M.D., a Mayo Clinic urologist and senior author of the study. “Urologic surgeons need to consider long-term health consequences for patients with small renal mass undergoing complete nephrectomy.”

According to Dr. Thompson, less than 25 percent of patients who are treated surgically for small kidney tumors undergo a partial nephrectomy in the United States. “The fact that this is being performed in less than a quarter of cases raises a quality of care concern,” he says, adding that more study is needed.

Source: Mayo Clinic

Related stories:

New model predicts whether patients will be free of renal cancer 12 years after initial treatment
A UT Southwestern Medical Center physician and other researchers have developed a unique statistical model that predicts the probability of a patient being cancer free 12 years after initial surgical treatment.
Kidney cancer surgery often determined by surgeons' practice style, not medical factors
A new study reveals that the type of surgery a patient with kidney cancer receives depends more on the surgeon’s preference than on the patient’s tumor size, demographic characteristics, or general medical health. The findings indicate that patients with kidney cancer often may not be receiving the most appropriate surgical care. The study is published in the April 15, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
Single-port laparoscopic surgery performed
A U.S. surgeon has performed the world's first single-port laparoscopic surgeries, including kidney removal and four other procedures.
Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
Surgeons specializing in laparoscopic procedures at UT Southwestern Medical Center have successfully removed a patient’s kidney by performing a unique nephrectomy entirely through the belly button.
Too much calcium in blood may increase risk of fatal prostate cancer
Men who have too much calcium in their bloodstreams may have an increased risk of fatal prostate cancer, according to a new analysis from Wake Forest University School of Medicine and the University of Wisconsin.
Battling diabetes with beta cells
Affecting eight percent of America's population, diabetes can lead to blindness, kidney failure, strokes and heart disease. Thanks to Tel Aviv University researchers, a new cure –– based on advances in cell therapy –– may be within reach.
Researchers piece together gene 'network' linked to schizophrenia
Reporting this week in the Archives of General Psychiatry, researchers at the Johns Hopkins University School of Medicine have uncovered for the first time molecular circuitry associated with schizophrenia that links three previously known, yet unrelated proteins.
Global study shows telmisartan reduces outcome of cardiovascular death, heart attack or stroke
An international study led by Canadian researchers has found that telmisartan, a medication used to lower blood pressure, reduced the outcome of cardiovascular death, heart attack or stroke in people who are unable to tolerate a widely available and effective standard treatment.

News discussion:

Medicine & Health news